Taiwan National Health Insurance Research Database chen metformin

Taiwan national health insurance research database chen metformin


Study was conducted using the Taiwan National Health Insurance Research Database.Hsiao, “Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan's National Health Insurance Research Database,” Journal of Diabetes and its Complications, vol.In this population-based cohort study using the Taiwan National Health Insurance Research Database (NHIRD),.A comparison group consisted of age-matched women without PCOS (n = 28,697).Methods: Using the Taiwan National Health Insurance Research Database from 2001 to 2013, 68205 subjects with type 2 diabetes were enrolled in the study cohort Methods.Metformin users were patients who received ≥90 cumulative defined daily doses within 1year before the index date.We conducted Taiwan National Health Insurance Research Database chen metformin a cohort study using the National Health Insurance Research Database in Taiwan between 1997 and 2013.Among new‑onset COPD‑T2DM patients, 65,370 were prescribed metformin and 2nd‑ line OADs before the date of COPD onset.From January 1, 2004, to December 31, 2012, a total of 373 metformin and 1260 non-metformin lung cancer cohorts with type 2 DM and EGFR-TKI treatment were studied We aimed to assess the safety of metformin in patients with type 2 diabetes and advanced (approximately stage 5) chronic kidney disease.Among new‑onset COPD‑T2DM patients, 65,370 were prescribed metformin and 2nd‑ line OADs before the date of COPD onset.From January 1, 2004, to December 31, 2012, a total of 373 metformin and 1260 non-metformin lung cancer cohorts with type 2 DM and EGFR-TKI treatment were studied.The study population included 645,710 patients with type 2 diabetes and not using other anti-diabetic medication from a subset of the Taiwan National Health Insurance Research Database.Materials and Methods Data sources, settings and ethics.Methods: Using the Taiwan National Health Insurance Research Databases, 5075 adolescents with atopic diseases (atopic cohort) and 44,729 without (non-atopic cohort) aged between 10 and 17 in 2000 were enrolled into our study and followed to the end of 2010.Of these patients, those who used metformin were categorized as the user group, and the remaining were classified as the non-user group TB close contacts with diabetes mellitus (DM) and normal renal function were selected from the National Health Insurance Research Database of Taiwan.Using the National Health Insurance Research Database, we identified 17 760 patients with DM and new‐onset hemodialysis between 2001 and 2013.3 Division of Environmental Health and Occupational Medicine of the National Health Research Institutes, Zhunan, Taiwan; Aim: To investigate the risk of diverticula of intestine associated with metformin use.16% of the whole population in 2000 and rose to 99% by the end of 2004 Using the Taiwan National Health Insurance Research Database, they collected data on all patients recently diagnosed with type 2 diabetes from January 2001 to December 2013, dividing them into two.Among them, 45524 were metformin users and 22681 were nonusers.Methods: This retrospective cohort study used the Taiwan’s National Health Insurance database to enroll 307,548 ever users and 18,839 never users of metformin.

National chen taiwan research metformin database insurance health


The metformin and nonmetformin groups were followed until the end of 2013 Objective To evaluate the effects of metformin use on the survival of inoperable non-small cell lung cancer (NSCLC) patients with diabetes using the Taiwanese National Health Insurance Research Database.Methods: We conducted a cohort study using the National Health Insurance Research Database in Taiwan between 1997 and 2013.Materials and Methods Data sources, settings and ethics.For each metformin user, a propensity-score matched metformin nonuser and an.Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date.To address confounding by indication.Results: Metformin use was significantly associated with a Taiwan National Health Insurance Research Database chen metformin reduced risk of death (hazard ratio: 0.Each AECOPD case was matched to 4 randomly selected controls according.We conducted this study to compare the morbidity and mortality associated with UTI and sepsis, between metformin users and nonusers in patients with diabetes.Methods:Using the Taiwan National Health Insurance Research Database from 2001 to 2013, 68205 subjects with type 2 diabetes were enrolled in the study cohort.10 Using a retrospective cohort approach, the.The researchers used the Taiwan National Health Insurance Research Database, to collect data on all patients recently diagnosed with type 2 diabetes from January 2001 to December 2013, dividing them into two groups: Those who took metformin (45,524 patients) and those who did not (22,681 patients)..This retrospective cohort study used the nationwide database of Taiwan’s National Health Insurance to investigate whether metformin would reduce the risk of acute appendicitis in patients with.Using the National Health Insurance Research Database, we identified 17 760 patients with DM and new‐onset hemodialysis between 2001 and 2013.The investigators collected information about patients diagnosed with type 2 diabetes between January 2—1 through December 2013 from the Taiwan National Health Insurance Research Database.Purpose: This population-based, retrospective cohort study was to investigate whether metformin is associated with a lower risk of subsequent age-related macular degeneration (AMD) in patients with type 2 diabetes.New-onset psychiatric illness (emerging after the diagnosis of PCOS) were identified in the medical record.For each metformin user, a propensity-score matched metformin nonuser and an.As such, 40,774 propensity score-matched metformin users and nonusers were identified from Taiwan’s National Health Insurance Research Database, between 1 January 2000 and 31 December 2017..The metformin and nonmetformin groups were followed until the end of 2013 Database (LHID), a representative subset of the National Health Insurance Research Database (NHIRD) in Taiwan.The LHID comprises information on one million National Health Insurance (NHI) beneficiaries in Taiwan, sampled at random from the population-wide NHI registry based on the population in the year 2000 and covered all claims data.Methods:Using the Taiwan National Health Insurance Research Database from 2001 to 2013, 68205 subjects with type 2 diabetes were enrolled in the study cohort.Subjects who developed major depression or bipolar disorder during the follow-up were.Research design and methods In total, 7,620 patients were eligible in this study, among them, 3,578 patients were metformin users and 4,042 were non-users H.Among them, 45524 were metformin users and 22681 were nonusers.Among them, 45524 were metformin users and 22681 were nonusers.Methods TB close contacts with diabetes mellitus (DM) Taiwan National Health Insurance Research Database chen metformin and normal renal function were selected from the National Health Insurance Research Database of Taiwan.The information was divided into a group of those who took metformin (45,524) and those who did not (22,681) Methods: A nationwide, population-based cohort study was conducted using the Taiwan National Health Insurance Research Database.This population-based, retrospective cohort study was to investigate whether metformin is associated with a lower risk of subsequent age-related macular degeneration (AMD) in patients with type 2 diabetes.Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date.Of these patients, those who used metformin were categorized as the user group, and the remaining Taiwan National Health Insurance Research Database chen metformin were classified as the non-user group Methods and Results.In this population-based cohort study using the Taiwan National Health Insurance Research Database (NHIRD), we demonstrated the protective effect of metformin against RVO in diabetes mellitus (DM) and explored the incidence rate and factors associated.Methods: We conducted a cohort study using the National Health Insurance Research Database in Taiwan between 1997 and 2013.For each met formin user, a propensity-score matched metformin nonuser.Each AECOPD case was matched to 4 randomly selected controls according.Hypertension was defined either by a diagnosis or by a diagnosis plus the use of angiotensin converting enzyme inhibitors/angiotensin receptor.Methods We did a retrospective, observational, cohort study of patients with type 2 diabetes who were enrolled prospectively in Taiwan’s national health insurance research database between Jan 1, 2000, and.From there the patients were split into 2 groups: those who took metformin (45,524 patients) and those who did not (22,681) Purpose.The effects of metformin on venous thrombosis in patient with type 2 DM have not been.Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.